Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRC/BTS phase II feasibility trial of mesothelioma management
ISRCTN54469112Phase 2Completed
- Sponsor
- Medical Research Council
- Start
- Sep 2000
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of mitomycin c, vinblastine, cisplatin and vinorelbine in mesothelioma (3 arms), sponsored by Medical Research Council. Primary endpoints: Acceptability of the study design to patients, Suitability of EORTC QLQ-C30, EORTC LC13, and FACT-L questionnaires and 1 more. Started Sep 2000; status: completed.
02
Drugs
mitomycin cvinblastinecisplatinvinorelbine
03
Conditions
mesothelioma
Beyond the preview
Go deeper on ISRCTN54469112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN54469112.